Ascertain
Series A in 2025
Ascertain is a collaborative venture between Northwell Health and Aegis Ventures, aimed at transforming healthcare through innovative company creation. This organization focuses on systematically developing, launching, and commercializing healthcare AI companies, utilizing a comprehensive platform that integrates medical, technological, data, and business resources. By addressing critical issues related to quality, equity, and cost in healthcare, Ascertain seeks to improve patient care and experience. The organization is dedicated to placing patient needs at the forefront of its business models and technology solutions, ultimately striving to enhance long-term health outcomes and advance the overall quality of care.
Avandra Imaging
Venture Round in 2025
Avandra Imaging is a health technology company that facilitates the sharing and analysis of medical imaging and clinical data. It aims to accelerate medical research and improve patient care by providing a comprehensive data ecosystem for pharmaceutical companies, medical device manufacturers, and researchers.
Truveta is a healthcare data platform that collaborates with physicians, life science researchers, and various stakeholders in the healthcare community. The company focuses on aggregating and de-identifying medical records from its partner organizations, enabling it to provide valuable insights into treatment outcomes and health factors. Initially concentrating on COVID-19, Truveta aims to accelerate medical research, empower clinicians with expert knowledge, and assist families in making informed healthcare decisions. By connecting treatments with results, Truveta enhances the understanding of health data to drive improvements in patient care.
Prolucent
Series A in 2024
Prolucent Health specializes in technology and services aimed at optimizing healthcare workforce management. The company offers a platform that leverages artificial intelligence and advanced analytics to address labor needs through data-driven decision-making. By modernizing recruitment and improving the utilization and cost of healthcare labor, Prolucent enables employers to effectively manage both full-time and contingent workforce components. Additionally, the platform engages healthcare workers, helping them discover suitable job opportunities.
Clarapath
Series B in 2024
Clarapath, Inc. is a medical robotics company that specializes in automating laboratory processes for digital pathology applications. Founded in 2011 and headquartered in New York, the company has developed Section Star, an automated device that streamlines microtomy through a tape transfer method. Clarapath provides a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory caters to both human and animal digital pathology needs, serving academic researchers and clinical laboratories. The company aims to enhance the quality and efficiency of lab medicine while reducing costs and labor-related delays. By integrating its technologies, Clarapath facilitates real-time access to tissue samples, thereby standardizing and simplifying the histology process and improving safety and throughput in laboratory settings.
Hume AI, established in 2021, specializes in developing AI models that enable technology to understand and respond to human emotions. Headquartered in New York and San Jose, the company offers a range of products, including expression measurement models, text-to-speech models, and speech-language models, all grounded in advanced research from psychology and machine learning. Hume AI's technology analyzes facial expressions, voice inflections, text, and other data sources to gain insights into human feelings and engagement. By prioritizing scientific rigor and ethical AI practices, Hume AI serves diverse industries, enhancing human-technology interactions with empathy and authenticity.
Optain is a manufacturer of medical equipment and software focused on enhancing healthcare accessibility for all individuals. The company specializes in developing retinal imaging technology that allows for noninvasive real-time diagnosis of eye and systemic health conditions. By leveraging advanced artificial intelligence and automation, Optain enables the use of the eye as a diagnostic tool to detect and prevent diseases in their early stages. This innovative approach facilitates prompt and accurate identification of various eye conditions, thereby supporting healthcare providers in delivering effective clinical assistance solutions that simplify illness screening anytime and anywhere.
Memora Health
Venture Round in 2023
Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.
Neuvotion
Seed Round in 2023
Neuvotion is a medical device company focused on developing neurostimulation products aimed at the rehabilitation and physical therapy markets. The company harnesses targeted neurostimulation and artificial intelligence to restore movement and independence for individuals experiencing movement impairments, such as those arising from strokes or injuries. By enabling users to actively guide their own therapy, Neuvotion provides a patient-centered approach to rehabilitation. Additionally, it offers clinicians advanced tools to monitor patient progress both in-person and remotely, enhancing the therapeutic value of their interventions.
Hume AI, established in 2021, specializes in developing AI models that enable technology to understand and respond to human emotions. Headquartered in New York and San Jose, the company offers a range of products, including expression measurement models, text-to-speech models, and speech-language models, all grounded in advanced research from psychology and machine learning. Hume AI's technology analyzes facial expressions, voice inflections, text, and other data sources to gain insights into human feelings and engagement. By prioritizing scientific rigor and ethical AI practices, Hume AI serves diverse industries, enhancing human-technology interactions with empathy and authenticity.
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.
Lazzaro Medical
Corporate Round in 2022
Lazzaro Medical is a company focused on addressing the needs of patients suffering from tracheobronchomalacia (TBM). It develops a medical device aimed at restoring healthy breathing through minimally invasive surgical techniques. This innovative device facilitates the repair of tracheobronchomalacia, effectively addressing respiratory issues related to tracheal and bronchial conditions. By enabling doctors to perform surgeries with reduced risk, Lazzaro Medical significantly shortens patient recovery times from months to days, thereby improving overall patient outcomes.
Playback Health
Seed Round in 2022
Playback Health, Inc., based in Mount Kisco, New York, specializes in developing patient engagement technology for healthcare enterprises. Its platform enables practitioners to create, store, and share personalized multimedia content, such as videos and documents, to educate patients about their specific health conditions, treatments, and post-care instructions. This content can be securely shared with family members, friends, or other healthcare professionals, providing a holistic view of the patient's healthcare experience. The company's AI-driven software integrates with existing systems like EMRs and patient portals, automating communication processes and improving patient satisfaction. Currently, Playback Health is deployed in 30 hospitals and care organizations across the United States.
Violet is a platform that helps the healthcare industry deliver more inclusive services. It enables identity-centered care for everyone.
Health Note
Series A in 2022
Health Note is an AI chatbot platform based in San Francisco, California, founded in 2018. The company specializes in health data management, focusing on enhancing patient encounters by streamlining the collection of patient information. By sending an SMS link to patients, Health Note connects them to its AI-driven chatbot, which gathers pre-visit data and formats it into physician notes. This process simplifies documentation for healthcare providers and integrates seamlessly with existing electronic medical record systems, ensuring a frictionless experience without the need for app downloads or sign-ins. Health Note optimizes clinic workflows and encourages patient engagement in their own care.
Brightline
Series C in 2022
Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.
Ascertain
Seed Round in 2022
Ascertain is a collaborative venture between Northwell Health and Aegis Ventures, aimed at transforming healthcare through innovative company creation. This organization focuses on systematically developing, launching, and commercializing healthcare AI companies, utilizing a comprehensive platform that integrates medical, technological, data, and business resources. By addressing critical issues related to quality, equity, and cost in healthcare, Ascertain seeks to improve patient care and experience. The organization is dedicated to placing patient needs at the forefront of its business models and technology solutions, ultimately striving to enhance long-term health outcomes and advance the overall quality of care.
Transcarent
Series C in 2022
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.
Nova Leah
Venture Round in 2021
Nova Leah Ltd, founded in 2015 and headquartered in Dundalk, Ireland with an additional office in Boston, Massachusetts, specializes in developing SelectEvidence, a comprehensive cybersecurity risk analysis and management solution tailored for medical device manufacturers and healthcare providers. The company offers continuous software updates, 24/7 technical support, and online platform training to ensure the security assurance of medical devices throughout their lifecycle. Nova Leah's approach emphasizes knowledge development, sharing, and collaboration to enhance cybersecurity compliance in the medical field.
Holmusk
Venture Round in 2021
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.
Clarapath
Series B in 2021
Clarapath, Inc. is a medical robotics company that specializes in automating laboratory processes for digital pathology applications. Founded in 2011 and headquartered in New York, the company has developed Section Star, an automated device that streamlines microtomy through a tape transfer method. Clarapath provides a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory caters to both human and animal digital pathology needs, serving academic researchers and clinical laboratories. The company aims to enhance the quality and efficiency of lab medicine while reducing costs and labor-related delays. By integrating its technologies, Clarapath facilitates real-time access to tissue samples, thereby standardizing and simplifying the histology process and improving safety and throughput in laboratory settings.
Cognixion
Seed Round in 2021
Cognixion, Inc. is a technology company focused on developing innovative solutions for individuals with communication disabilities. The company specializes in biosignal recognition software, particularly through its flagship product, Speakprose, which utilizes a brain-computer interface (BCI) to translate brainwaves into speech, allowing non-verbal individuals to communicate. In addition to software, Cognixion also creates hardware, including a speech-generating device and a sensory communication system that integrates eye tracking technology. Founded in 2014 and based in Santa Barbara, California, Cognixion aims to enhance the quality of life for individuals with severe speech impairments and other disabilities by enabling them to express themselves and interact with their environment using thought alone.
Truveta is a healthcare data platform that collaborates with physicians, life science researchers, and various stakeholders in the healthcare community. The company focuses on aggregating and de-identifying medical records from its partner organizations, enabling it to provide valuable insights into treatment outcomes and health factors. Initially concentrating on COVID-19, Truveta aims to accelerate medical research, empower clinicians with expert knowledge, and assist families in making informed healthcare decisions. By connecting treatments with results, Truveta enhances the understanding of health data to drive improvements in patient care.
Conversa Health
Series B in 2021
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Conversa Health
Series B in 2020
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Peerbridge Health
Venture Round in 2019
Peerbridge Health Inc. is a digital health company specializing in advanced remote monitoring solutions for vital signs. The company develops a wireless electrocardiogram (ECG) monitor, Peerbridge Cor, which provides real-time heart data to physicians and allows for continuous arrhythmia detection over seven days. In addition to Peerbridge Cor, the company offers products like Peerbridge CorHRV and Peerbridge Cor+, which monitor a range of vital signs including heart rate rhythm, respiratory rate, temperature, oxygen saturation, and heart rate variability. Founded in 2012 in New York by Angelo Acquista, Peerbridge Health holds two pioneering patents for medical-grade monitoring of vital signs, with additional patents pending. By enhancing the accuracy and affordability of diagnoses, Peerbridge Health aims to improve patient outcomes and support various medical, wellness, and performance-based monitoring needs.
Gauss Surgical
Series C in 2018
Gauss Surgical, Inc. is a medical technology company that specializes in real-time blood monitoring solutions to enhance patient outcomes in surgical and obstetric settings. Founded in 2011 and headquartered in Los Altos, California, Gauss Surgical develops the Triton system, which includes various models suited for different medical needs. Triton assists healthcare professionals in monitoring and estimating blood loss during procedures, allowing for timely intervention in cases of hemorrhage. The system offers objective metrics for blood loss, thereby facilitating better clinical decision-making regarding transfusions. Serving the healthcare sector primarily in the United States, Gauss Surgical's products are designed to integrate seamlessly into existing medical practices, using sophisticated algorithms and HIPAA-compliant technology to deliver accurate monitoring in real time.
Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.
Vestagen
Venture Round in 2017
Vestagen Technical Textiles is a company based in Orlando, Florida, that specializes in the development, manufacturing, and marketing of advanced textile products and technologies. Founded in 2009, Vestagen holds exclusive North American rights to patented Swiss technologies for medical textiles, which can be adapted for various applications, including medical uniforms and athletic apparel. The company focuses on addressing the critical need for continuous-wear solutions in the healthcare industry. Its flagship product, VESTEX Active Barrier, is designed to protect healthcare workers and patients by significantly reducing the risks associated with fluid exposure during routine use of general-purpose attire. This innovative fabric helps to minimize the acquisition and retention of harmful microorganisms on clothing, enhancing safety in healthcare settings.
Salaso Health Solutions
Venture Round in 2017
Salaso is a developer of a software as a service platform that enables physiotherapists and other healthcare professionals to prescribe and deliver high-quality exercise videos to patients via smartphones, tablets, or personal computers. The platform includes an e-learning tool designed to engage patients with the content and promote adherence to prescribed home exercise programs. By facilitating the delivery of physiotherapy exercises, Salaso aims to support the recovery process for patients recovering from injuries, ensuring that healthcare providers can effectively manage and monitor their patients' rehabilitation efforts.
Conversa Health
Series A in 2017
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Peerbridge Health
Venture Round in 2017
Peerbridge Health Inc. is a digital health company specializing in advanced remote monitoring solutions for vital signs. The company develops a wireless electrocardiogram (ECG) monitor, Peerbridge Cor, which provides real-time heart data to physicians and allows for continuous arrhythmia detection over seven days. In addition to Peerbridge Cor, the company offers products like Peerbridge CorHRV and Peerbridge Cor+, which monitor a range of vital signs including heart rate rhythm, respiratory rate, temperature, oxygen saturation, and heart rate variability. Founded in 2012 in New York by Angelo Acquista, Peerbridge Health holds two pioneering patents for medical-grade monitoring of vital signs, with additional patents pending. By enhancing the accuracy and affordability of diagnoses, Peerbridge Health aims to improve patient outcomes and support various medical, wellness, and performance-based monitoring needs.
HealthReveal
Series A in 2017
HealthReveal is a company that offers a cloud-based platform for clinical analytics. This platform uses advanced analytics and biomonitoring technology to continually monitor and analyze patient physiology and care by integrating real-time data streams from various sources like clinical, operational, and biometric data. The primary goal of HealthReveal's platform is to ensure adherence to evidence-based care guidelines, enabling early detection and treatment of chronic diseases, which can help patients recover faster and reduce healthcare costs.
Clarapath
Venture Round in 2017
Clarapath, Inc. is a medical robotics company that specializes in automating laboratory processes for digital pathology applications. Founded in 2011 and headquartered in New York, the company has developed Section Star, an automated device that streamlines microtomy through a tape transfer method. Clarapath provides a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory caters to both human and animal digital pathology needs, serving academic researchers and clinical laboratories. The company aims to enhance the quality and efficiency of lab medicine while reducing costs and labor-related delays. By integrating its technologies, Clarapath facilitates real-time access to tissue samples, thereby standardizing and simplifying the histology process and improving safety and throughput in laboratory settings.
PurpleSun
Venture Round in 2016
PurpleSun is an early stage healthcare technology company based out of New York City. They are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention, diagnostics and treatment. Their company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection. Their goal is to prevent healthcare acquired infections, which will ultimately save lives, reduce costs and enhance safety for patients and caregivers. Their clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.
Avizia is a provider of telehealth and remote conferencing solutions designed to facilitate comprehensive telehealth programs within healthcare systems. The company focuses on enhancing collaborative care by connecting medical professionals across distances through its innovative telemedicine platform. Avizia’s end-to-end solution encompasses telemedicine devices, workflow management software, and integration with electronic health records, alongside a variety of peripherals such as digital stethoscopes and examination cameras. This platform allows healthcare providers to conduct remote medical consultations and training sessions, simulating an in-person experience. By leveraging advanced video technology, Avizia enables real-time, high-definition video collaboration among patients and healthcare professionals, thereby streamlining care coordination and expanding access to medical expertise.